5-hydroxytryptophan has been researched along with fluorodopa f 18 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambrosini, V; Castellucci, P; Fanti, S; Morigi, JJ; Nanni, C | 1 |
Giovanella, L; July, M; Santhanam, P; Treglia, G | 1 |
2 review(s) available for 5-hydroxytryptophan and fluorodopa f 18
Article | Year |
---|---|
Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
Topics: 5-Hydroxytryptophan; Carbon Radioisotopes; Dihydroxyphenylalanine; Gallium Radioisotopes; Humans; Image Enhancement; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin | 2018 |